Novel accurate therapy for Multiple Sclerosis: Optimization of antisense oligonucleotides delivery and functionality in primary T cells
Principal Investigator(s)
Ross, Corrina
Collaborating Institutions
AutoImmunity Biologic Solutions
Inc
Funded by
National Institutes of Health
Research Start Date
Status
Active
The research proposed here aims to optimize the delivery and functionality of a novel, biological therapy that bypasses the broad immunosuppressive mechanisms of current drugs in primary T cells, thereby addressing a major potential hurdle for this therapy.